Article

Manufacturers Dodge Pharmacists' Efforts to Control Drug Costs

Pharmaceutical manufacturers are pretty good at finding new ways to make a profit on their drugs.

A recent article in the New York Times titled “Drug Makers Sidestep Barriers on Pricing” reminded me that pharmaceutical manufacturers are pretty good at finding new ways to make a profit on their drugs.

When there’s greater pressure to control price increases, the manufacturers find other ways to make money, such as “circumvent(ing) efforts of insurers and pharmacists to switch patients to the generic components, or even to the over-the-counter versions,” the article explains.

As you read these types of stories about the ways drug companies are making the health care system work to their advantage, you start to wonder whether profits are getting in the way of care quality and costs.

What do you think should be done? Let me know via e-mail at Fred@ncpharmacists.org or Twitter @eckel_fred

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com